Recruiting
Adjuvant Pancreatic Therapy Guided by MRD
NCT06966440
- Conditions
- Pancreatic Adenocarcinoma Resectable
- Locations
-
- Ruijing Hospital Shanghai, China
Clinical trial condition
Pancreatic Adenocarcinoma Resectable
Explore clinical trials studying Pancreatic Adenocarcinoma Resectable. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Pancreatic Adenocarcinoma Resectable trial results
NCT03410030
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
Completed
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
NCT03750669
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- The second affiliated hospital of Zhejiang University Hangzhou, Zhejiang, China
NCT01715142
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- Antwerp University Hospital (UZA) Edegem, Antwerpen, Belgium
- Erasme University Hospital (ULB) Brussels, Belgium